HSP90 is a key for telomerase activation and malignant transition in pheochromocytoma.

Boltze C, Lehnert H, Schneider-Stock R, Peters B, Hoang-Vu C, Roessner A

Open source

DOI
10.1385/endo:22:3:193
Published
2003 Dec
Container
Endocrine
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1385/endo:22:3:193,
  title = {HSP90 is a key for telomerase activation and malignant transition in pheochromocytoma.},
  author = {Boltze C and Lehnert H and Schneider-Stock R and Peters B and Hoang-Vu C and Roessner A},
  year = {2003},
  journal = {Endocrine},
  doi = {10.1385/endo:22:3:193},
  url = {https://doi.org/10.1385/endo:22:3:193}
}

RIS

TY  - JOUR
TI  - HSP90 is a key for telomerase activation and malignant transition in pheochromocytoma.
AU  - Boltze C
AU  - Lehnert H
AU  - Schneider-Stock R
AU  - Peters B
AU  - Hoang-Vu C
AU  - Roessner A
PY  - 2003
JO  - Endocrine
DO  - 10.1385/endo:22:3:193
UR  - https://doi.org/10.1385/endo:22:3:193
ER  - 

APA

C, B., H, L., R, S., B, P., C, H., & A, R. (2003). HSP90 is a key for telomerase activation and malignant transition in pheochromocytoma.. Endocrine. https://doi.org/10.1385/endo:22:3:193

Source records